- Home
- REPL vs XMTR Comparison
REPL vs XMTR Comparison
Compare REPL & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- XMTR
- Stock Information
- Founded
- REPL 2015
- XMTR 2013
- Country
- REPL United States
- XMTR United States
- Employees
- REPL N/A
- XMTR N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- XMTR Industrial Machinery/Components
- Sector
- REPL Health Care
- XMTR Technology
- Exchange
- REPL Nasdaq
- XMTR Nasdaq
- Market Cap
- REPL 897.3M
- XMTR 1.0B
- IPO Year
- REPL 2018
- XMTR 2021
- Fundamental
- Price
- REPL $12.49
- XMTR $41.67
- Analyst Decision
- REPL Strong Buy
- XMTR Buy
- Analyst Count
- REPL 6
- XMTR 9
- Target Price
- REPL $17.50
- XMTR $33.63
- AVG Volume (30 Days)
- REPL 1.3M
- XMTR 586.3K
- Earning Date
- REPL 02-06-2025
- XMTR 11-05-2024
- Dividend Yield
- REPL N/A
- XMTR N/A
- EPS Growth
- REPL N/A
- XMTR N/A
- EPS
- REPL N/A
- XMTR N/A
- Revenue
- REPL N/A
- XMTR $525,128,000.00
- Revenue This Year
- REPL N/A
- XMTR $19.60
- Revenue Next Year
- REPL $300.41
- XMTR $19.06
- P/E Ratio
- REPL N/A
- XMTR N/A
- Revenue Growth
- REPL N/A
- XMTR 21.19
- 52 Week Low
- REPL $4.92
- XMTR $11.08
- 52 Week High
- REPL $17.00
- XMTR $42.00
- Technical
- Relative Strength Index (RSI)
- REPL 50.53
- XMTR 84.59
- Support Level
- REPL $11.19
- XMTR $35.46
- Resistance Level
- REPL $12.79
- XMTR $41.43
- Average True Range (ATR)
- REPL 0.70
- XMTR 2.68
- MACD
- REPL -0.14
- XMTR 0.40
- Stochastic Oscillator
- REPL 52.21
- XMTR 97.11
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of the revenue is earned from the U.S. segment.